Stephanie Lesage
Co-founder & Chief Executive Officer Oxford Silk Phage Technologies
Seminars
Thursday 26th March 2026
Reimagining Infection Prevention with Phage-Enhanced Medical Devices to Reduce Cardio Vascular-Associated Infections & Beyond
4:10 pm
- Introducing bacteriophage-integrated biotextiles as a novel class of medical devices designed to prevent rather than treat infection
- Outlining pre-clinical validation progress and regulatory considerations for establishing phage-based infection prevention as a new medical-device standard
- Exploring future opportunities for precision prevention, tailoring phage-loaded devices to patients prone to recurrent infections
